High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group

Overview of attention for article published in Journal of Hematology & Oncology, October 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 43 Dimensions

Readers on

mendeley: 45 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 43 publications that cite this research output.

43

The most recent citing publications are shown below. View all 43 publications that cite this research output on Dimensions.

Aberrant ecotropic viral integration site-1 (EVI-1) and myocyte enhancer factor 2 C gene (MEF2C) in adult acute myeloid leukemia are associated with adverse t (9:22) & 11q23 rearrangements

Article in Annals of Hematology (May 2024)

HIPK3 maintains sensitivity to platinum drugs and prevents disease progression in gastric cancer

Article in Cancer Letters (January 2024)

Decoding the genetic symphony: Profiling protein-coding and long noncoding RNA expression in T-acute lymphoblastic leukemia for clinical insights

Article in PNAS Nexus (January 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.